KINASET THERAPEUTICS Trademark

Trademark Overview

On Monday, December 14, 2020, a trademark application was filed for KINASET THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the KINASET THERAPEUTICS trademark a serial number of 90978226. The federal status of this trademark filing is REGISTERED as of Tuesday, November 15, 2022. This trademark is owned by Kinaset Therapeutics, Inc.. The KINASET THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of pharmaceuticals and therapeutics
kinaset therapeutics

General Information

Serial Number90978226
Word MarkKINASET THERAPEUTICS
Filing DateMonday, December 14, 2020
Status700 - REGISTERED
Status DateTuesday, November 15, 2022
Registration Number6902992
Registration DateTuesday, November 15, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 25, 2022

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesDevelopment of pharmaceuticals and therapeutics

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 22, 2021
Primary Code042
First Use Anywhere DateSaturday, October 31, 2020
First Use In Commerce DateSaturday, October 31, 2020

Trademark Owner History

Party NameKinaset Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMedfield, MA 02052
US
Party NameKinaset Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMedfield, MA 02052
US
Party NameKinaset Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMedfield, MA 02052
US

Trademark Events

Event DateEvent Description
Thursday, December 17, 2020NEW APPLICATION ENTERED
Monday, February 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, June 5, 2021ASSIGNED TO EXAMINER
Tuesday, June 15, 2021NON-FINAL ACTION WRITTEN
Tuesday, June 15, 2021NON-FINAL ACTION E-MAILED
Tuesday, June 15, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 2, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, December 2, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, December 2, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 2, 2021ASSIGNED TO LIE
Thursday, December 2, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, December 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 20, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 25, 2022PUBLISHED FOR OPPOSITION
Tuesday, January 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 6, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, September 6, 2022TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, September 21, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 6, 2022DIVISIONAL REQUEST RECEIVED
Thursday, September 22, 2022DIVISIONAL PROCESSING COMPLETE
Tuesday, September 6, 2022USE AMENDMENT FILED
Thursday, September 22, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, October 13, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, October 14, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 15, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, November 15, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, April 17, 2026TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 17, 2026APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 17, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 17, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 17, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

therapeutics kinaset pharmaceuticals development